"Confirming the Global Potential of K-Pharma and Biotech"

Daewoong Pharmaceutical announced on the 13th that Lee Eogwon, Chairman of the Financial Services Commission, visited Daewoong Pharmaceutical's smart plant in Osong, North Chungcheong Province, on the 13th to discuss the competitiveness of the pharmaceutical and biotech industry and policy finance support measures.

Lee Seungha, Division Head at Daewoong Pharmaceutical (left), is explaining the production process of the Osong smart plant to Lee Eokwon, Chair of the Financial Services Commission. Daewoong Pharmaceutical

Lee Seungha, Division Head at Daewoong Pharmaceutical (left), is explaining the production process of the Osong smart plant to Lee Eokwon, Chair of the Financial Services Commission. Daewoong Pharmaceutical

View original image

This visit was arranged as part of the government's schedule to examine the feasibility of applying the "National Growth Fund" to industrial sites. The event was attended by officials from the financial sector, including Korea Development Bank and Industrial Bank of Korea, as well as the company's management.


Daewoong Pharmaceutical stated that it has invested a cumulative total of about 1 trillion won in production infrastructure with the aim of entering global markets. It also explained that it reinvests about 15% of its sales in research and development and is expanding open innovation with biotech companies.


The Osong smart plant visited by the delegation is operated based on a system that automatically records process data. The company emphasized that it has secured data integrity by adopting a structure in which the process is automatically halted if it deviates from quality standards. It added that this system meets the requirements of global regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).


The National Growth Fund being promoted by the government is a public-private joint policy finance project aimed at fostering advanced strategic industries. Daewoong Pharmaceutical said it plans to use the policy funds for research and development and production infrastructure to accelerate its entry into global markets.



Chairman Lee Eogwon of the Financial Services Commission said, "On the ground at the smart plant, I was able to confirm the potential of Korea's pharmaceutical and biotech industry," adding, "We will provide support so that policy finance can translate into investment by innovative companies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing